At the 2026 ACP Internal Medicine Meeting, Dr. Douglas S. Paauw detailed current medication challenges, from persistent ADHD drug shortages to evolving GLP-1 safety profiles. He explained that recalls ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results